1. Home
  2. NXL vs UBXG Comparison

NXL vs UBXG Comparison

Compare NXL & UBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • UBXG
  • Stock Information
  • Founded
  • NXL 2010
  • UBXG 2018
  • Country
  • NXL United States
  • UBXG China
  • Employees
  • NXL N/A
  • UBXG N/A
  • Industry
  • NXL Medical Specialities
  • UBXG
  • Sector
  • NXL Health Care
  • UBXG
  • Exchange
  • NXL Nasdaq
  • UBXG Nasdaq
  • Market Cap
  • NXL 10.0M
  • UBXG 9.5M
  • IPO Year
  • NXL 2022
  • UBXG 2024
  • Fundamental
  • Price
  • NXL $2.87
  • UBXG $3.50
  • Analyst Decision
  • NXL Hold
  • UBXG
  • Analyst Count
  • NXL 1
  • UBXG 0
  • Target Price
  • NXL N/A
  • UBXG N/A
  • AVG Volume (30 Days)
  • NXL 377.2K
  • UBXG 36.4K
  • Earning Date
  • NXL 03-26-2025
  • UBXG 12-31-2024
  • Dividend Yield
  • NXL N/A
  • UBXG N/A
  • EPS Growth
  • NXL N/A
  • UBXG N/A
  • EPS
  • NXL N/A
  • UBXG N/A
  • Revenue
  • NXL $162,078.00
  • UBXG $51,600,106.00
  • Revenue This Year
  • NXL $56.86
  • UBXG N/A
  • Revenue Next Year
  • NXL $167.44
  • UBXG N/A
  • P/E Ratio
  • NXL N/A
  • UBXG N/A
  • Revenue Growth
  • NXL 26.00
  • UBXG N/A
  • 52 Week Low
  • NXL $0.30
  • UBXG $0.26
  • 52 Week High
  • NXL $4.49
  • UBXG $35.44
  • Technical
  • Relative Strength Index (RSI)
  • NXL 42.81
  • UBXG N/A
  • Support Level
  • NXL $2.80
  • UBXG N/A
  • Resistance Level
  • NXL $3.54
  • UBXG N/A
  • Average True Range (ATR)
  • NXL 0.38
  • UBXG 0.00
  • MACD
  • NXL -0.02
  • UBXG 0.00
  • Stochastic Oscillator
  • NXL 14.53
  • UBXG 0.00

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

Share on Social Networks: